Evidence map›Paper›PMID 41746553›Full record

ArticleJournal of community genetics2026

Health care providers' perceptions of screening for risk of type 1 diabetes in newborns using genetic risk scores.

Rebecca Wright, Emily Cheves, Sa'Nealdra T Wiggins, Rebecca R Moultrie, Ana Forsythe, Sara M Andrews, Hannah Frawley, Heidi L Cope, Holly L Peay

Abstract read
In one paragraph

Article in Journal of community genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rebecca WrightCenter for Genomics and Applied Public Health, RTI International, 3040 East Cornwallis Rd, Research Triangle Park, NC, USA. rwright@rti.org.ORCID http://orcid.org/0009-0006-5151-576X
Emily ChevesCenter for Genomics and Applied Public Health, RTI International, 3040 East Cornwallis Rd, Research Triangle Park, NC, USA.ORCID http://orcid.org/0000-0001-8801-0411
Sa'Nealdra T WigginsCenter for Genomics and Applied Public Health, RTI International, 3040 East Cornwallis Rd, Research Triangle Park, NC, USA.ORCID http://orcid.org/0000-0002-6155-1418
Rebecca R MoultrieCenter for Genomics and Applied Public Health, RTI International, 3040 East Cornwallis Rd, Research Triangle Park, NC, USA.ORCID http://orcid.org/0000-0003-2102-2287
Ana ForsytheCenter for Genomics and Applied Public Health, RTI International, 3040 East Cornwallis Rd, Research Triangle Park, NC, USA.ORCID http://orcid.org/0009-0000-0370-0772
Sara M AndrewsCenter for Genomics and Applied Public Health, RTI International, 3040 East Cornwallis Rd, Research Triangle Park, NC, USA.ORCID http://orcid.org/0000-0003-0218-0976
Hannah FrawleyCenter for Genomics and Applied Public Health, RTI International, 3040 East Cornwallis Rd, Research Triangle Park, NC, USA.ORCID http://orcid.org/0000-0002-0919-5524
Heidi L CopeCenter for Genomics and Applied Public Health, RTI International, 3040 East Cornwallis Rd, Research Triangle Park, NC, USA.ORCID http://orcid.org/0000-0003-0586-9277
Holly L PeayCenter for Genomics and Applied Public Health, RTI International, 3040 East Cornwallis Rd, Research Triangle Park, NC, USA.ORCID http://orcid.org/0000-0002-3053-7453

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To explore health care providers’ perceptions of using polygenic risk scores (PRS) to screen newborns for the risk of developing type 1 diabetes (T1D) prior to its implementation in Early Check, an expanded newborn screening program in North Carolina (NC), an online survey was conducted with pediatric providers in NC followed by interviews with a subset of providers who responded to the survey. Forty-eight providers completed the survey, and 14 participated in an interview. Participants identified improved health outcomes, provider decision-making, and parental decision-making as the primary potential benefits of screening for risk of T1D. Increased parental anxiety, insufficient provider knowledge, and out-of-pocket expenses for families were described as significant potential barriers. Participants requested tools for educating parents on screening and results, guidelines for follow-up and when to refer to a specialist, and access to a genetic counselor for questions. Participants were generally supportive of screening for T1D risk using PRS, though barriers need to be addressed to optimize the practice for widespread clinical use. This study fills a gap in the literature related to providers’ attitudes and perspectives on screening for T1D using PRS in newborns.

Indexed as

Newborn screeningPolygenic risk scoresType 1 diabetes

Identifiers

PMID41746553
PMCPMC12946544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.